Continuous Glucose Monitoring (CGM) in an Underserved Population
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorTulane University
About this trial
The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide better care for an underserved population. This will be a pilot study to evaluate the feasibility of such a trial in this population before doing a larger multicenter trial.
Eligibility criteria
Qualifiers
Age 18-75 years
Type 2 diabetes mellitus
HbA1C ≥ 7.5%
At least on 1 insulin injection therapy daily
Disqualifiers
Type 1 diabetes mellitus
Currently on CGM or using insulin pump
Advanced renal disease or Estimated Glomerular Filtration Rate (eGFR) <40
Serious co-morbidities which in the investigator's opinion, will make it challenging for patients to participate
Trial design
Treatments tested in this trial
- Continuous Glucose Monitoring (CGM)
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
1University Medical Center70112, New OrleansLouisiana, United States
Sponsors and collaborators
Tulane University
Lead sponsor
Abbott
Collaborator
Source ClinicalTrials.gov